https://www.selleckchem.com/pr....oducts/donafenib-sor
The Israel National Cancer Registry (INCR) was established in 1960. Reporting has been mandatory since 1982. All neoplasms of uncertain/unknown behavior, in situ and invasive malignancies (excluding basal and squamous cell carcinomas of the skin), and benign neoplasms of the brain and central nervous system (CNS) are reportable. To assess completeness and timeliness of the INCR for cases diagnosed or treated in 2005. Abstractors identified cases of in situ and invasive malignancies and tumors of benign and uncertain behav
Aimer
Commentaire
Partagez
